Page last updated: 2024-11-02

pamidronate and Sarcoma, Synovial

pamidronate has been researched along with Sarcoma, Synovial in 2 studies

Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)

Research Excerpts

ExcerptRelevanceReference
"Tumor-induced hypercalcemia is a frequent complication of advanced cancers, but it has been rarely reported in patients with sarcoma."1.34Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma. ( Badiei, Z; Hiradfar, M; Vakili, R; Zabolinejad, N, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osanai, T1
Tsuchiya, T1
Sugawara, M1
Vakili, R1
Hiradfar, M1
Zabolinejad, N1
Badiei, Z1

Other Studies

2 other studies available for pamidronate and Sarcoma, Synovial

ArticleYear
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2009, Volume: 14, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neopla

2009
Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma.
    Journal of pediatric endocrinology & metabolism : JPEM, 2007, Volume: 20, Issue:7

    Topics: Adolescent; Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Male; Mediastin

2007